Delivery Order SPE2DR25D3301-SPE2DR26F19CM
- Not listed
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used for serious systemic fungal infections. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,906.55 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of AmBisome 50 mg vials. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. AmBisome is an antifungal medication used to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,099.14 with an ultimate completion date of August 25, 2025. The contract was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $21,536.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Ambisome on December 1, 2025, with an ultimate completion date of December 2, 2025. This competitive award, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,098.20 order is for the supply of the antifungal medication AMBISOME 50 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,938.00 by the Defense Logistics Agency (DLA) on October 27, 2025, with an ultimate completion date of October 28, 2025. The delivery order is for AmBisome 50 mg vials, a specialty pharmaceutical product. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,923.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2023. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19CMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,788.50 to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used to treat serious fungal infections in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 9, 2025. The award was issued on December 8, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide through this prime contract vehicle. The company's extensive federal contracting history demonstrates its capability to fulfill specialized medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 12/7/25 |